Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)
ClinicalTrials.gov study NCT03657043. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
ClinicalTrials.gov study NCT01447706. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer
ClinicalTrials.gov study NCT02978222. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ova
ClinicalTrials.gov study NCT02580058. IPD Sharing: YES. Countries: 25. Publications: 3.
Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT03955471. IPD Sharing: NO. Countries: 1. Publications: 1.
Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT00526799. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)
ClinicalTrials.gov study NCT05092360. IPD Sharing: UNDECIDED. Countries: 14. Publications: 1.
Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
ClinicalTrials.gov study NCT01450761. IPD Sharing: Not stated. Countries: 34. Publications: 1.
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
ClinicalTrials.gov study NCT01844986. IPD Sharing: YES. Countries: 15. Publications: 6.
A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT03414047. IPD Sharing: YES. Countries: 8. Publications: 1.
PLATINUM Diversity
ClinicalTrials.gov study NCT02240810. IPD Sharing: Not stated. Countries: 1. Publications: 5.
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT03522246. IPD Sharing: Not stated. Countries: 24. Publications: 2.
A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00556712. IPD Sharing: Not stated. Countries: 28. Publications: 1.
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
ClinicalTrials.gov study NCT01498692. IPD Sharing: UNDECIDED. Countries: 6. Publications: 2.
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With Hi
ClinicalTrials.gov study NCT04209855. IPD Sharing: Not stated. Countries: 21. Publications: 2.
Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00842712. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy
ClinicalTrials.gov study NCT03904108. IPD Sharing: NO. Countries: 1. Publications: 24.
Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02413320. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)
ClinicalTrials.gov study NCT01968213. IPD Sharing: Not stated. Countries: 11. Publications: 6.
Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients
ClinicalTrials.gov study NCT03402841. IPD Sharing: YES. Countries: 19. Publications: 11.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.